Some syringes retain a tiny amount of liquid in the hub
Discontinuation Rates Treatment Discontinuation Due to Adverse Events: Retatrutide 9mg: 12.2% Retatrutide 12mg: 18.2% Placebo: 4.0% Interestingly, some discontinuations were attributed to "perceived excessive weight loss" participants felt they were losing weight too rapidly or had reached their desired weight and chose to discontinue
Therefore, the development of novel therapies targeting postprandial hyperglycemia, which could improve both cardiovascular outcomes and healthy life expectancy, has been sought
Women researchers typically use far lower doses, usually 5mg to 10mg weekly, focusing on the metabolic and body composition benefits while minimizing androgenic effects
1 Separating Myth from Fact Myth : Anyone can take GLP-1 weight-loss drugs
Furthermore, GLP-1R activation can prevent arterial restenosis through inhibiting VSMC proliferation and migration via stress-associated endoplasmic reticulum protein 1 (SERP1) [131]
